Takeda renames heartburn drug to avoid errors
Thursday, March 4, 2010 - 12:14
in Health & Medicine
(AP) -- Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.